featured
Cytotoxic Tumor-Infiltrating Lymphocytes for Predicting Outcomes in Metastatic HER2-Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
JAMA Oncol 2017 Jul 27;[EPub Ahead of Print], S Liu, B Chen, S Burugu, S Leung, D Gao, S Virk, Z Kos, WR Parulekar, L Shepherd, KA Gelmon, TO NielsenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.